The Anthelmintic Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Anthelmintic Drugs Market?
The Anthelmintic Drugs Global Market has seen robust growth in the past years. The market size has escalated from $3.16 billion in 2024 to $3.34 billion in 2025. This constitutes a compound annual growth rate (CAGR) of 5.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Anthelmintic Drugs Industry?
The Anthelmintic Drugs Global Market Report 2025 expects the market to reach $4.11 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.3%.
Download Your Free Sample of the 2025 Anthelmintic Drugs Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Anthelmintic Drugs Market?
The key drivers in the anthelmintic drugs market are:
• Increasing cases of parasitic infections worldwide
• Growing usage of anthelmintics in livestock and pets
• Rising awareness and health initiatives globally
• Increased international travel contributing to the spread of parasites
Global Market Segmentation: Identifying Major Anthelmintic Drugs Industry Segments
The anthelmintic drugsmarket covered in this report is segmented –
1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics
Pre-order the 2025 Anthelmintic Drugs Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Anthelmintic Drugs Market?
The key trends in the anthelmintic drugs market are:
• Rising demand for combination therapies is an emerging trend in the anthelmintic drugs market.
• There is a significant focus on drug resistance management, shaping the future of the market.
• The adoption of personalized medicine is increasingly popular in the anthelmintic drugs industry.
• Telemedicine is expanding in treatment monitoring, marking a crucial trend for the future development of the market.
Who Are the Top Competitors & Leading Players in the Anthelmintic Drugs Market?
Major companies in the anthelmintic drugs market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Bayer AG
• Sanofi S.A.
• Novartis AG
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Limited
• Zoetis Inc.
• Hetero Labs Limited
• Sun Pharmaceutical Industries Ltd.
• Galderma S.A.
• Cipla Inc.
• Ferring Pharmaceuticals Inc.
• Amneal Pharmaceuticals, Inc.
• Zydus Lifesciences Limited
• Glenmark Pharmaceuticals Ltd.
• Mankind Pharma Ltd.
• Reese Pharmaceutical Company
Regional Dominance: Which Area Leads the Global Anthelmintic Drugs Market?
North America was the largest region in the anthelmintic drugs market in 2024
